Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Stanley Druckenmiller’s Dividend Stocks Include Merck

Page 1 of 2

We track 13F filings from hedge funds and other notable investors for a variety of purposes. First, we have found that the most popular small cap stocks among hedge funds earn an average excess return of 18 percentage points per year (learn more about our small cap strategy) and we are looking for other potential strategies. Second, we like to review top picks from investment managers and treat them as a source of free recommendations for further research. When we went through the 13F from billionaire Stanley Druckenmiller (who previously managed Duquesne Capital and was also a top portfolio manager for George Soros) we noticed a number of high yield stocks among his top picks (see the full list of stocks Druckenmiller reported owning). Here are five stocks which Druckenmiller had over $20 million invested in at the beginning of January and which pay dividend yields of 3.5% or higher going by current prices and recent dividend policy:

One of the billionaire’s five largest holdings by market value was his 2.4 million shares of Merck & Co., Inc. (NYSE:MRK), which was 22% more shares than he had owned three months earlier. As a large pharmaceutical company, Merck does not have much exposure to economic conditions and so the stock’s beta is 0.4. The dividend yield is nearly 4%, though the company did report lower revenue and earnings last quarter than in the fourth quarter of 2011. Merck had made our list of the most popular healthcare stocks among hedge funds for the fourth quarter of 2012 (find more healthcare stocks hedge funds loved).

DUQUESNE CAPITALDruckenmiller did cut his stake in fellow drug manufacturer Eli Lilly & Co. (NYSE:LLY) but still owned 1.4 million shares of the $61 billion market cap company. That valuation places Eli Lilly at 15 times trailing earnings, though revenue and earnings were both down slightly in the fourth quarter of 2012 versus a year earlier and so it’s not necessarily a value stock. The dividend yield here is 3.5%, with a beta similar to Merck’s. Renaissance Technologies, founded by billionaire Jim Simons, reported a position of 8.1 million shares at the end of December (check out Renaissance’s stock picks).

The billionaire also liked a number of utilities paying high dividend yields:

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!